Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

FDA Asks For Additional Study For Acadia’s Pimavanserin In Alzheimer’s-Associated Delusions

By Vandana Singh
August 5, 7:55 AM
The FDA has issued a Complete Response Letter (CRL) to Acadia Pharmaceuticals Inc (NASDAQ:ACAD) regarding its supplemental marketing application for pimavanserin in…

ACAD

Read More
2 minute read
  • Biotech
  • General

Genmab and BioNTech Expand Global Collaboration To Include Development Of Monospecific Antibody Candidates To Address Malignant Solid Tumors

By Bill Haddad
August 5, 6:47 AM
Collaboration expands to include development of monospecific antibody candidates to address malignant solid tumors Expanded collaboration leverages Genmab's proprietary HexaBody® technology platform to

BNTX

Read More
1 minute read
  • Biotech
  • Broad U.S. Equity ETFs
  • ETFs
  • General
  • Markets
  • News
  • Short Ideas
  • Small Cap
  • Specialty ETFs
  • Trading Ideas

Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead

By Bhavik Nair
August 5, 12:32 AM
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.

ARKK

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan
August 4, 6:07 PM
 

ARQT

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks

Marker Therapeutics Shares Jump 60 Percent As FDA Announced Clearance To Blood Cell Cancer Study

By Ragothaman Srinivasan
August 4, 5:01 PM
The U.S. Food and Drug Administration (FDA) announced clearance to Marker Therapeutics’ (NASDAQ: MRKR) Investigational New Drug (IND) application for MT-601 for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma.

MRKR

Read More
1 minute read
  • Biotech
  • Exclusives
  • General
  • Movers
  • Penny Stocks
  • Trading Ideas

Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer’s Data

By Adam Eckert
August 4, 4:05 PM
Shares of biopharmaceutical company Alzamend Neuro Inc (NASDAQ: ALZN) are soaring Thursday afternoon after Cognition Therapeutics Inc (NASDAQ: CGTX) shares surged following the presentation of a proteomic

ALZN

Read More
2 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

US Officials Declare Health Emergency Over Monkeypox Outbreak As Cases Cross 6,000 Mark: Report

By Vandana Singh
August 4, 3:01 PM
The Biden administration has officially declared monkeypox a public health emergency as cases continue to rise in the U.S., the Wall Street Jour

AEMD

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks

Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China

By Vandana Singh
August 4, 2:19 PM
Innovent Biologics Inc (OTC:IVBXF) and Sanofi SA (NASDAQ:SNY) have collaborated to develop and commercialize two Sanofi clinical-stage oncology assets – Phase 3 SAR408701…

IVBXF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition

By Vandana Singh
August 4, 1:47 PM
Pfizer Inc (NYSE:PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM of PF-07265803, indicated…

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years

By Vandana Singh
August 4, 12:44 PM
Novavax Inc (NASDAQ:NVAX) has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of two doses of…

NVAX

Posts pagination

Previous 1 … 701 702 703 … 733 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service